• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
cnb1383_liver-model-drug-safety_webinar_nav-ad_v1
  • About us
  • News
  • Events
  • Careers
cn-bio-organ-on-a-chip-logo
  • Products
    • PhysioMimix® OOC Microphysiological Systems
    • Consumables
      • PhysioMimix® multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Gut/Liver-on-a-chip
    • Lung-on-a-chip
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Technology
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers in Biotech
  • Contact us

Explore our solutions


PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.

PhysioMimix OOC

physiomimix-single-and-multi-organ-on-a-chip-systems
Learn more

Consumables

Multi-chip plates
3D validated cells
NASH-in-a-box
Bioavailability assay kit: Human 18
DILI assay kit: Human 24
Learn more

Models

Single-organ models
- Liver-on-a-chip model
- Lung-on-a-chip model
Multi-organ models
- Gut/Liver-on-a-chip models

Support packages

PhysioMimix® support packages

Discover the applications


Investigate the application areas that our PhysioMimix® products and services support

Learn more

Disease modeling

Metabolic dysfunction-associated steatohepatitis
Hepatitis B
Pulmonary infection
Learn more

Safety toxicology

Drug-induced liver injury
Immune-mediated liver injury
Learn more

ADME

Drug absorption
Drug metabolism
Drug bioavailability
Oligonucleotide delivery
Learn more

Studies as a service


Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

Learn more
icon-nash-1-150x150.png MASLD/MASH
icon-dili-tox-150x150.png Drug-induced liver injury
icon-adme-150x150.png ADME

PhysioMimix® Human 3D Cell Culture wins Lab Innovation 2018 Award

November 22, 2018

The PhysioMimix® benchtop 3D cell culture system from CN Bio has won the Innovation Award at the UK’s largest laboratory event, held at the NEC Birmingham in November.

PhysioMimix® allows researchers to set up assays and generate results quickly. Scientists and technicians can culture micro-tissues that mimic the structure and function of human organs and run a wide range of assays and experiments.

CN Bio Commercial Director Paul Davies said: “It was great to see how hands-on and enthusiastic scientists were with PhysioMimix at the meeting. Since the system is very portable, we’re enjoying demonstrating how easy it is to set up and run.”

“But most importantly we’ve had some great discussions about how the human-organ-on-chip assays on PhysioMimix® can support human-centred data and insights and help people meet a whole range of their research goals. In particular, Organ-on-Chip studies can help scientists to zero in on drug targets, toxicity mechanisms and drug-drug interactions, gaining critical data early in the assessment of new therapies.”

“Lab Innovations hosts hundreds of products launches every year,” said Alison Willis, Divisional Director at Easyfairs which manages Lab Innovations 2018. “We are delighted that this year’s Innovation Award went to CN Bio, celebrating a truly disruptive product, the PhysioMimix® Organs-on-Chips System, and we look forward to seeing future developments from this pioneering startup.”

For further information, please contact:

CN Bio:

P: +44 (0) 1707 358 739

E: [email protected]

Category iconPress releases

Primary Sidebar

Other recent news

  • Microphysiological systems for mAbs development: how do they address animal limitations? May 1, 2025
  • Why the FDA animal testing phase-out for monoclonal antibodies? May 1, 2025
  • NIH to prioritize human-based research technologies & reduce animal use in research April 29, 2025
  • CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform April 24, 2025
  • FDA’s plan to phase out animal testing requirement for monoclonal antibodies and other drugs with more human-relevant methods April 10, 2025

Speak to our experts

Request a meeting with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Regulatory | Accessibility
Website terms | Terms of sale

Product Recycling

©2025 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • Microphysiological systems for mAbs development: how do they address animal limitations? May 1, 2025
  • Why the FDA animal testing phase-out for monoclonal antibodies? May 1, 2025
  • NIH to prioritize human-based research technologies & reduce animal use in research April 29, 2025
Cyber Essentials Logo